Market Tracker

05/04 3:42am ET

Immunomedics Inc (NASDAQ:IMMU)

3.75
Delayed Data
As of May 03
 +0.07 / +1.90%
Today’s Change
1.50
Today|||52-Week Range
5.05
+22.15%
Year-to-Date

Today’s Trading

Previous close3.68
Today’s open3.68
Day’s range3.42 - 3.76
Volume1,441,706
Average volume (3 months)956,477
Market cap$348.6M
Dividend yield--
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+18.63%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENTLEntellus Medical Inc-0.33-2.23%
ARAYAccuray Inc-0.20-3.63%
AXGNAxoGen Inc-0.04-0.70%
CUTRCutera Inc+0.19+1.68%
Data as of 3:59pm ET, 05/03/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts